Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02296239

Ligand	Ligand name	Chain	PDB	Tanimoto
ALN	NAPHTHALEN-2-YL-3-ALANINE	A,B,I,J	2FIV	0.73
ALN	NAPHTHALEN-2-YL-3-ALANINE	A,B	1B0H	0.73
ALN	NAPHTHALEN-2-YL-3-ALANINE	B	1FIV	0.73
ALN	NAPHTHALEN-2-YL-3-ALANINE	A,B,I,J	3FIV	0.73
APH	P-AMIDINOPHENYL-3-ALANINE	E,I	1PPC	0.71
APH	P-AMIDINOPHENYL-3-ALANINE	H	1ETS	0.71
APH	P-AMIDINOPHENYL-3-ALANINE	H	1ETT	0.71
APH	P-AMIDINOPHENYL-3-ALANINE	I	1QUR	0.71
1PA	PHENYLMETHYLACETIC ACID ALANINE	I	1BHF	0.74
APE	(1-AMINO-2-PHENYL-ETHYL)-CARBAMIC ACID	E,I	1SCN	0.71
A70	N-ethyl-N-[(4-methylpiperazin-1-yl)carbonyl]-D-phenylalanyl-N-[(1S,2S,4R)-4-(butylcarbamoyl)-1-(cyclohexylmethyl)-2-hydroxy-5-methylhexyl]-L-norleucinamide	A	1ZAP	0.71
4AF	4-ACETYL-L-PHENYLALANINE	A	1ZH6	0.72
BIR	N-[3-[(1-AMINOETHYL)(HYDROXY)PHOSPHORYL]-2-(1,1'-BIPHENYL-4-YLMETHYL)PROPANOYL]ALANINE	A	1R1H	0.73
BIR	N-[3-[(1-AMINOETHYL)(HYDROXY)PHOSPHORYL]-2-(1,1'-BIPHENYL-4-YLMETHYL)PROPANOYL]ALANINE	L	3B7R	0.73
4PH	4-methyl-L-phenylalanine	B,C	3BV9	0.77
002	N-[(2R)-2-BENZYL-4-(HYDROXYAMINO)-4-OXOBUTANOYL]-L-ISOLEUCYL-L-LEUCINE	A,B	2FV9	0.76
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A,B	2ZOF	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A	2HPT	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A	1TXR	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A	1XRY	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A	2EK9	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A	1HS6	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A	2DQM	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A	3EBH	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A	1GW6	0.77
BES	2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID	A,B	2ZOG	0.77
0A9	methyl L-phenylalaninate	A	1AY2	0.77
0A9	methyl L-phenylalaninate	I	5ER1	0.77
0A9	methyl L-phenylalaninate	I,P	1HDT	0.77
APL	N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE	B,C	1GG6	0.72
BIF	(R)-2-AMINO-3-(4-PHENYLCYCLOHEXYL)PROPANOIC ACID	G,M,P,S	1YYL	0.75
BIF	(R)-2-AMINO-3-(4-PHENYLCYCLOHEXYL)PROPANOIC ACID	G,M,P,S	2I5Y	0.75
AIP	ANTIPAIN	A,B	1BCR	0.77
BAV	(3S,14R,16S)-16-[(1R)-1-hydroxy-2-{[3-(1-methylethyl)benzyl]amino}ethyl]-3,4,14-trimethyl-1,4-diazacyclohexadecane-2,5-dione	A,B,C	3DV5	0.73
APM	M-AMIDINOPHENYL-3-ALANINE	E	1PPH	0.71
APD	3-METHYLPHENYLALANINE	A,B,C	1GMY	0.77
APF	1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	B,C	1GG6	0.73
APF	1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	G	6GCH	0.73
5FH	(5S)-5-benzylimidazolidine-2,4-dione	A	2JLO	0.76
44U	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	B,D	3DA9	0.72